Site icon pharmaceutical daily

Biologic API CDMO Benchmarking Report 2022: Compare your Company’s Performance Against its Competitors – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biologic API CDMO Benchmarking (7th Ed.)” report has been added to ResearchAndMarkets.com’s offering.

The Biologic API CDMO Benchmarking (7th Edition)report brings with it a wealth of knowledge and information created with two goals in mind, help biopharmaceutical companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 22 performance attributes specific to outsourced drug substance manufacturing. In this Consumer Reports-style analysis, ISR presents data on 411 service encounters from 134 respondents who have been involved in outsourced biologic API projects in the past 18 months.

What you will learn:

Drug Developers

Contract Manufacturers

Major Topics:

Key Topics Covered:

How to Use this Report

Analysis Note: Outsourcing Requirement

Introduction

Methodology

Demographics

Number of Ratings per Company

Major Sections

Outsourcing Philosophies and Practices

CMO Selection Drivers

CMO Perceptions and Interactions

CMO Performance and Loyalty

Biologic API CMO Competitive Landscape

Company Service Quality Profiles

Study Data

Demographics

About the Publisher

For more information about this report visit https://www.researchandmarkets.com/r/ii8e3j

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version